Description

Citimax (citicoline) solution for infusions 10 mg/ml. 100 ml. vial

Ingredients

Each ml contains 10 mg of citicoline.

Dosage

The recommended dosage is determined by a healthcare professional based on the patient’s condition. It is typically administered intravenously over a specific period.

Indications

Citimax is indicated for the treatment of neurological disorders associated with acute ischemic stroke. It may also be used in cases of head injury or cognitive disorders.

Contraindications

Do not use Citimax if you are allergic to citicoline or any of the other ingredients. It is not recommended for use in pregnant or breastfeeding women.

Directions

Citimax should be administered by a healthcare professional in a clinical setting. The infusion rate and duration should be carefully monitored.

Scientific Evidence

Citicoline, the active ingredient in Citimax, has shown promising results in various studies for its neuroprotective and cognitive-enhancing effects. Research published in the Journal of Neurology, Neurosurgery & Psychiatry demonstrated that citicoline significantly improved cognitive function in patients with mild vascular cognitive impairment.

Additional Information

Citimax works by increasing levels of neurotransmitters in the brain, promoting neuronal membrane repair, and enhancing brain metabolism. Clinical trials have highlighted its potential in improving outcomes in patients with acute ischemic stroke when administered promptly after the event.

Compared to other neuroprotective agents, Citimax has shown favorable results with a good safety profile. It is well-tolerated and has minimal side effects, making it a promising option in the management of neurological conditions.